MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 263 filers reported holding MEDICINES CO in Q3 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $66,588,000 | +69.9% | 783,950 | 0.0% | 6.18% | +41.5% |
Q3 2019 | $39,197,000 | +114.7% | 783,950 | +56.6% | 4.37% | +143.1% |
Q2 2019 | $18,260,000 | +335.6% | 500,700 | +233.8% | 1.80% | +374.4% |
Q1 2019 | $4,192,000 | -80.7% | 150,000 | -79.4% | 0.38% | -81.4% |
Q3 2018 | $21,750,000 | -18.5% | 727,205 | 0.0% | 2.04% | -14.9% |
Q2 2018 | $26,688,000 | +168.1% | 727,205 | +140.6% | 2.40% | +162.8% |
Q1 2018 | $9,954,000 | +318.6% | 302,205 | +247.4% | 0.91% | +343.7% |
Q4 2017 | $2,378,000 | -26.2% | 87,001 | 0.0% | 0.21% | -37.0% |
Q3 2017 | $3,222,000 | -2.5% | 87,001 | 0.0% | 0.33% | -28.8% |
Q2 2017 | $3,306,000 | – | 87,001 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |